Analyst Research Report Snapshot

Title:

ALK-ABELLÓ - A BREATH OF FRESH AIR

Price:

$10.00

Provider:

Edison Investment Research

Date:

29 Jul 2013

Pages:

2

Type:

AcrobatPDF

Companies referenced:

ALKb.CO

Available for Immediate Download
Summary:

Positive pivotal house dust mite (HDM) allergy data are key to ALK-Abelló’s investment case, both as a therapy for one of the most common year-round allergies, and to treat HDM-induced allergic asthma. These data pave the way for EU filing in 2014 and should drive further development by global partners. The key near-term drivers are likely to be potential US approvals for the grass and ragweed allergy tablets, expected in 2014.

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.